A patient with transthyretin amyloidosis (ATTR) who received the investigational gene therapy nexiguran ziclumeran (nex-z) in ...
The FDA previously placed two clinical studies on hold, including the Phase III trial in which the liver toxicity occurred.
The liver is vital to the body because it performs several vital functions that cannot be attained without it being healthy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback